CytoMed Therapeutics
GDTC
#10859
Rank
NZ$18.57 M
Marketcap
NZ$1.57
Share price
-6.50%
Change (1 day)
-53.32%
Change (1 year)

CytoMed Therapeutics (GDTC) - Total liabilities

Total liabilities on the balance sheet as of December 2025 : NZ$1.47 Million

According to CytoMed Therapeutics's latest financial reports the company's total liabilities are NZ$1.47 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

CytoMed Therapeutics - Total liabilities on balance sheet (from 2021 to 2025)

Total liabilities by year

Year Total liabilities Change
2025-12-31NZ$1.52 M13.9%
2024-12-31NZ$1.33 M-0.81%
2023-12-31NZ$1.34 M-75.3%
2022-12-31NZ$5.45 M44.22%
2021-12-31NZ$3.78 M8.06%
2020-12-31NZ$3.49 M